AAAAAA
Results: 76-94/94
Authors:
Camblor, MA
Diaz-Cabanas, MJ
Cox, PA
Shannon, IJ
Wright, PA
Morris, RE
Citation: Ma. Camblor et al., A synthesis, MAS NMR, synchrotron X-ray powder diffraction, and computational study of zeolite SSZ-23, CHEM MATER, 11(10), 1999, pp. 2878-2885
Authors:
Gummert, JF
Otto, G
Barten, MJ
Morris, RE
Citation: Jf. Gummert et al., Effect of anesthesia on a whole blood lymphocyte proliferation assay in the rat, IMMUNOPH IM, 21(2), 1999, pp. 267-276
Authors:
Coupar, PI
Jaffres, PA
Morris, RE
Citation: Pi. Coupar et al., Synthesis and characterisation of silanol-functionalised dendrimers, J CHEM S DA, (13), 1999, pp. 2183-2187
Authors:
Morris, RE
Strawser, JR
Citation: Re. Morris et Jr. Strawser, An examination of the effect of CPA firm type on bank regulators' closure decisions, AUDITING, 18(2), 1999, pp. 143-158
Authors:
Chusuei, CC
Morris, RE
Schreifels, JA
Citation: Cc. Chusuei et al., Decomposition products of N,N '-disalicylidene-1,2-propanediamine adsorbedon 304 stainless steel, APPL SURF S, 153(1), 1999, pp. 23-34
Authors:
Slauson, SD
Silva, HT
Sherwood, SW
Morris, RE
Citation: Sd. Slauson et al., Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay, IMMUNOL LET, 67(3), 1999, pp. 179-183
Authors:
Ikonen, TS
Romanska, HM
Bishop, AE
Berry, GJ
Polak, JM
Morris, RE
Citation: Ts. Ikonen et al., Alterations in inducible nitric oxide synthase (iNOS) and nitrotyrosine (NitroY) during re-epithelialization of heterotopic rat tracheal composite grafts, TRANSPLAN P, 31(1-2), 1999, pp. 182-182
Authors:
Ikonen, TS
Gummert, JF
Honda, Y
Hayase, M
Perlroth, J
Hausen, B
Barlow, C
Fitzgerald, P
Yock, PG
Morris, RE
Citation: Ts. Ikonen et al., Development of models of graft vascular disease in nonhuman primates: Evaluation of GVD by intravascular ultrasound in a new cynomolgus model with arterial allograft exchange, TRANSPLAN P, 31(1-2), 1999, pp. 687-687
Authors:
Hausen, B
Boeke, K
Berry, GJ
Segarra, I
Benet, LZ
Christians, U
Morris, RE
Citation: B. Hausen et al., Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to ratlung allograft recipients - Potentiation of immunosuppressive efficacy andimprovement of tolerability by staggered versus simultaneous treatment, TRANSPLANT, 67(7), 1999, pp. 956-962
Authors:
Hausen, B
Boeke, K
Berry, GJ
Gummert, JF
Christians, U
Morris, RE
Citation: B. Hausen et al., Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model, TRANSPLANT, 67(3), 1999, pp. 354-359
Authors:
Lightfoot, P
Lethbridge, ZAD
Morris, RE
Wragg, DS
Wright, PA
Citation: P. Lightfoot et al., Synthesis and structure of an unusual new layered aluminophosphate containing oxalate groups. [NH3CH2CH2NH3](2.5)[Al4H(HPO4)(4)(H2PO4)(4)(H2PO4)(2)(C2O4)(4)], J SOL ST CH, 143(1), 1999, pp. 74-76
Authors:
Lethbridge, ZAD
Lightfoot, P
Morris, RE
Wragg, DS
Wright, PA
Kvick, A
Vaughan, G
Citation: Zad. Lethbridge et al., Hydrothermal syntheses and crystal structures of two new iron phosphates [C2N2H10](2+)[Fe(HPO4)(2)(OH)](2-)center dot H2O and KFe3(OH)(2)(PO4)(2)center dot 2H(2)O, J SOL ST CH, 142(2), 1999, pp. 455-460
Authors:
Gummert, JF
Barten, MJ
Sherwood, SW
Van Gelder, T
Morris, RE
Citation: Jf. Gummert et al., Pharmacodynamics of immunosuppression by mycophenolic acid: Inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics, J PHARM EXP, 291(3), 1999, pp. 1100-1112
Authors:
Strasser, JE
Newman, SL
Ciraolo, GM
Morris, RE
Howell, ML
Dean, GE
Citation: Je. Strasser et al., Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusionby Histoplasma capsulatum, J IMMUNOL, 162(10), 1999, pp. 6148-6154
Authors:
Jeremias, A
Kolz, ML
Ikonen, TS
Gummert, JF
Oshima, A
Hayase, M
Honda, Y
Komiyama, N
Berry, GJ
Morris, RE
Yock, PG
Fitzgerald, PJ
Citation: A. Jeremias et al., Feasibility of in vivo intravascular ultrasound tissue characterization inthe detection of early vascular transplant rejection, CIRCULATION, 100(21), 1999, pp. 2127-2130
Authors:
Poston, RS
Billingham, M
Hoyt, EG
Pollard, J
Shorthouse, R
Morris, RE
Robbins, RC
Citation: Rs. Poston et al., Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model, CIRCULATION, 100(1), 1999, pp. 67-74
Authors:
Segarra, I
Brazelton, TR
Guterman, N
Hausen, B
Jacobsen, W
Morris, RE
Benet, LZ
Christians, U
Citation: I. Segarra et al., Development of a high-performance liquid chromatographic electrospray massspectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin, J CHROMAT B, 720(1-2), 1998, pp. 179-187
Authors:
Gummert, JF
Ikonen, T
Briffa, N
Honda, Y
Hayase, M
Perlroth, J
Kobayashi, Y
Hausen, B
Barlow, C
Billingham, ME
Fitzgerald, P
Yock, PG
Robbins, RC
Morris, RE
Citation: Jf. Gummert et al., A new large-animal model for research of graft vascular disease, TRANSPLAN P, 30(8), 1998, pp. 4023-4023
Authors:
Gregory, CR
Stewart, A
Sturges, B
DeManvelle, T
Cannon, A
Ortega, T
Harb, M
Morris, RE
Citation: Cr. Gregory et al., Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy, TRANSPLAN P, 30(8), 1998, pp. 4143-4148